← Leaderboards
Donna M Huryn
University Of Pennsylvania
$1,783,438
Attributed
$6,054,037
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2020–24$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,054,037 · 6
By mechanism
UC2$3,178,608 · 1
R33$1,047,617 · 2
R01$825,965 · 1
R61$575,548 · 1
R21$426,299 · 1
Top collaborators
- Alan Davidson6 shared
- Mark P De Caestecker6 shared
- Neil A Hukriede6 shared
- Joseph A. Baur3 shared
- Tejvir S Khurana3 shared
- David Ryan Koes2 shared
- Partha Roy2 shared
- Andrew Paul Vandemark2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Joseph A. Baur$17,043,751
- David W Christianson$17,751,022
- Joseph G Sodroski$53,351,794
- Ali Naji$46,943,355
- Tejvir S Khurana$7,406,200
Others in their field
Other Emerging Leaders on “In Vitro”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Leonard Freedmand · Leidos Biomedical Research, Inc.$68,796,314
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
- John Damon Chodera · Sloan-Kettering Inst Can Research$34,949,884
- Tony Moody · Duke University$34,777,314
Research focus
In VitroPharmaceutical ChemistryCellsMouse ModelDesignDrug KineticsMetabolismCessation Of LifeDna DamageIn VivoSeriesPropertyAnalogStructureDisease ProgressionPharmaceutical PreparationsBasePlayMediatingCharacteristicsRecoveryPharmacologyMultidisciplinaryInjury
Grant awards (13)
Probing functional HIV-1 envelope glycoprotein conformations with novel potent CD4-mimetic compounds$825,965
R01 · FY2024 · AI
Therapeutic Optimization of Productive Repair After Acute Kidney Injury$601,717
UC2 · FY2024 · DK
Therapeutic Optimization of Productive Repair After Acute Kidney Injury$628,302
UC2 · FY2023 · DK
HTS to identify compounds that increase NAD+ levels in neurons and muscle cells$373,195
R33 · FY2023 · NS
Discovery of Cell-based Chemical Probes Targeting Aberrant Angiogenesis in the Eye$155,520
R21 · FY2023 · EY
Therapeutic Optimization of Productive Repair After Acute Kidney Injury$630,202
UC2 · FY2022 · DK
HTS to identify compounds that increase NAD+ levels in neurons and muscle cells$279,416
R33 · FY2022 · NS
Discovery of Cell-based Chemical Probes Targeting Aberrant Angiogenesis in the Eye$270,779
R21 · FY2022 · EY
Therapeutic Optimization of Productive Repair After Acute Kidney Injury$630,202
UC2 · FY2021 · DK
20-HETE Formation Inhibitors in Cardiac Arrest$395,006
R33 · FY2021 · NS · contact PI
Therapeutic Optimization of Productive Repair After Acute Kidney Injury$57,983
UC2 · FY2021 · DK
Therapeutic Optimization of Productive Repair After Acute Kidney Injury$630,202
UC2 · FY2020 · DK
HTS to identify compounds that increase NAD+ levels in neurons and muscle cells$575,548
R61 · FY2020 · NS